Do you consider consolidating the chest for patients with extensive stage SCLC with brain metastases with a PR/CR after whole brain RT and systemic chemotherapy?
These patients with brain metastases were excluded from the CREST study.
Answer from: Radiation Oncologist at Academic Institution
The obsession with survival, both for payment and utility, interferes with some benefits of XRT in ED. Many want to undo Slotman's two observations: incredible improvement in 1 year survival and brain freedom from failure despite persistence of disease in the chest; and improved 2 year surviva...